Herpes Zoster Viral (HZV) infection after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: a case series.
2021
We report the first cases of Varicella Zoster Viral (VZV) infection after AZD1222 and BNT162b2 COVID-19 mRNA vaccines in Greece. As the World Health Organization ( WHO) declared the coronavirus disease-2019 (COVID-19) as a pandemic, the production for a safe and effective vaccine COVID-19 became a global priority. 1 In December 2020, the European Medicines Agency (EMA) first approved the BNT162b2 (Pfizer-BioNTech COVID-19 mRNA) vaccine and the AZD1222 (Oxford/AstraZeneca COVID-19) vaccine. 2.
-
Correction
-
Source
-
Cite
-
Save
10
References
0
Citations
NaN
KQI